TSS:Rfhg 133719.1

Basic information about the TSS

---

TSS ID: rfhg_133719.1 TSS ID(Version3): hg_112871.1 hg_112869.1 hg_112870.1 Species: human Chr: chr11		Start: 6603726 End: 6603830 Strand: +
Source datasets	FANTOM5|PRJNA615891|DRA013844|PRJNA401781|PRJNA597322 |PRJNA548673|PRJNA4843412|PRJDB5282
Protocol	CAGE|SLIC_CAGE|TIF-seq2|RAMPAGE|STRIPE-seq|oligo_capping |ReCappable-seq|NETCAGE|C1CAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2418500,EH38E1517547)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000526711.5:0 ENST00000537806.5:0 ENST00000420936.6:0 ENST00000526114.5:0 ENST00000530016.5:0 ENST00000299421.9:0 ENST00000527121.5:0 ENST00000528995.5:0 ENST00000534565.1:0 ENST00000396751.6:0 AK293474:0 AK314843:0 U40282:0 AK296628:0 BC001554:0 AB209416:0 CR749220:0 GeneID: 3611 HGNC/MGI_ID: HGNC:6040 UniProt_ID: A0A087WW45 A0A0A0MTH3 E9PQ52 Q13418 Q59FP4 V9HWF0 Nearer transcript ids and distances: LF207831:-17 MA443408:-17 ENST00000532063.5:-18 EU794625:147 LF369386:162 MA604963:162 KJ897056:436 KJ905216:436 KR709573:436 ENST00000627400.1:442 CU674762:442 AB463785:442 CR407673:442 DQ891172:442 DQ894355:442 ENST00000526318.2:466 LF369387:472 MA604964:472 view more...

Gene_name: integrin linked kinase Gene_symbol: ILK Gene_synonyms: Gene_source: HGNC:6040

TATA-Box annotation

---

Distance to TSS:	4
Nearest PromoterID:	NM_001014794
Entrez ID:	3611
Nearest Unigene:	Hs.706355
Nearest Refseq:	NM_004517
Nearest Ensembl:	ENSG00000166333
Gene Name:	integrin linked kinase
Gene Alias:	HEL-S-28|ILK-1|ILK-2|P59|p59ILK
Gene Type:	protein-coding
CpG%:	0.144231
GC%:	0.790476
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ILK p2@ILK p3@ILK p4@ILK
Sample		p1@ILK	p2@ILK	p3@ILK	p4@ILK
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.96	0.97	1.17	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	12.75	2.23	1.21	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.72	0.96	1.35	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	10.60	0.62	1.25	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.22	2.02	1.12	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.50	0.78	1.74	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	17.43	1.09	2.83	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.05	1.70	1.21	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	13.25	1.07	0.85	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	20.87	2.90	5.80	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.02	2.43	4.85	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.20	3.25	7.72	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	24.98	1.45	0.48	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.81	2.26	0.75	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	26.35	0.88	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.62	1.01	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	23.15	0.44	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.93	0.42	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.99	0.00	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	23.32	1.81	2.11	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.13	0.94	0.94	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	31.76	0.69	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	24.82	0.78	1.55	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.66	1.70	1.46	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	22.19	0.26	1.03	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	24.69	1.90	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	0.55	0.55	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	28.76	1.65	1.65	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	28.75	0.65	1.13	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	30.58	0.36	1.27	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.01	0.21	1.26	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	22.66	0.20	2.15	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.58	1.48	0.84	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	26.23	0.33	2.14	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	26.37	1.12	2.06	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.95	0.96	1.72	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	29.43	0.82	3.07	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.23	1.81	1.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	27.01	1.35	1.08	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.09	1.68	2.64	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	30.35	1.65	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.01	0.73	2.05	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	28.05	1.69	5.06	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	36.01	1.57	2.62	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	36.74	1.61	2.61	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	39.08	1.63	3.26	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	34.79	1.44	4.56	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	36.36	1.19	4.17	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	35.67	1.91	2.87	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	34.58	1.21	5.05	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	26.44	1.43	6.35	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.69	1.78	6.45	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	35.49	1.06	2.13	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	47.39	3.65	3.98	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	39.43	3.36	14.26	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	38.58	0.46	13.32	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	41.49	1.62	6.48	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	44.64	2.25	3.85	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	44.95	2.51	11.00	4.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	50.76	1.41	7.05	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	54.40	2.80	5.61	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	38.21	1.59	46.18	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	44.85	2.38	25.82	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	53.94	1.30	15.60	5.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	61.41	2.48	13.13	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	0.00	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	165.85	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	63.38	1.46	9.75	6.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	50.58	0.00	8.93	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	48.79	1.41	9.85	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	37.76	0.99	4.97	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	47.64	0.31	3.71	3.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	53.51	2.14	3.06	1.83
Adipocyte - breast, donor1	11376-118A8	63.51	2.38	1.58	1.11
Adipocyte - breast, donor2	11327-117E4	61.60	3.53	0.32	1.12
Adipocyte - omental, donor1	11473-119C6	52.04	2.16	0.38	0.89
Adipocyte - omental, donor2	11474-119C7	100.91	3.74	1.49	2.99
Adipocyte - omental, donor3	11475-119C8	77.70	4.02	0.33	1.34
Adipocyte - perirenal, donor1	11476-119C9	77.20	1.28	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	35.18	2.20	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	40.65	1.81	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	35.45	2.09	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	44.20	1.37	0.00	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	19.30	0.51	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	25.93	3.07	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	24.69	1.18	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	28.31	1.37	0.24	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	22.27	1.94	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	17.60	2.13	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	12.80	1.67	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	29.11	1.25	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	22.35	1.00	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	24.22	0.98	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	15.53	1.83	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	48.40	3.09	1.10	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	107.22	5.74	3.23	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	39.53	2.40	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	45.52	1.80	1.44	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	56.90	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	50.75	1.03	0.41	0.62
Anulus Pulposus Cell, donor1	11248-116E6	54.01	2.17	0.11	0.34
Anulus Pulposus Cell, donor2	11463-119B5	60.49	3.67	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	70.09	2.25	4.94	4.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	57.31	2.17	2.60	3.91
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	25.68	4.28	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	50.82	3.29	4.48	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	55.64	1.26	5.06	6.32
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	47.53	2.64	1.32	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	52.63	2.60	4.55	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	63.11	4.37	4.85	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	35.63	1.78	4.75	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	59.13	3.01	3.39	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	60.23	2.90	2.90	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	32.60	1.25	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	63.26	2.47	3.29	2.47
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	54.59	1.36	1.36	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	56.09	1.81	2.41	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	53.04	1.61	2.14	4.82
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	64.05	2.08	2.46	3.40
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	51.59	0.80	3.74	2.94
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	47.80	5.85	5.85	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	60.70	3.32	3.98	2.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	37.22	3.60	3.60	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	77.88	0.00	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	53.86	2.74	1.54	2.23
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	53.88	1.46	1.46	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	61.09	4.55	4.17	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	38.76	3.63	3.63	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	67.83	1.71	1.71	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	60.07	2.57	2.57	2.78
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	54.20	1.55	3.87	2.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	71.32	2.82	2.82	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	59.17	1.61	3.54	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	48.51	2.14	2.85	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	61.42	1.75	3.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	64.73	1.81	2.71	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	57.02	3.56	4.75	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	51.36	4.07	3.56	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	61.89	3.31	4.08	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	43.21	1.91	4.45	3.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	53.94	1.73	5.18	4.75
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	75.15	2.54	4.66	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	37.41	1.74	2.90	1.74
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	61.41	3.78	7.56	4.72
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	73.74	3.22	5.26	2.88
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	0.00	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	63.38	2.11	2.11	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	68.18	3.65	3.43	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	43.92	1.20	2.41	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	58.32	2.92	2.19	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	69.88	3.22	2.99	2.76
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	58.66	5.10	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	47.54	2.54	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	59.25	4.13	3.10	2.89
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	45.29	1.53	2.14	2.14
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	56.88	0.48	3.82	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	66.74	1.77	2.66	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	51.88	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	40.99	3.32	2.77	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	52.16	3.18	2.91	2.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	38.16	2.54	1.45	1.82
Astrocyte - cerebellum, donor1	11500-119F6	69.27	4.79	0.98	1.23
Astrocyte - cerebellum, donor2	11580-120F5	108.86	7.19	1.88	1.37
Astrocyte - cerebellum, donor3	11661-122F5	65.02	1.89	1.68	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	42.53	1.39	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	48.86	2.59	0.49	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	69.06	4.03	1.34	2.24
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	34.86	2.87	1.03	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	28.19	3.38	0.75	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	26.40	2.96	0.91	0.57
Basophils, donor1	12241-129G9	23.54	1.83	0.52	0.78
Basophils, donor2	12242-129H1	18.76	1.08	2.53	0.00
Basophils, donor3	12243-129H2	22.34	0.59	1.47	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	23.72	0.65	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	53.03	1.83	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	57.74	2.51	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	63.63	2.08	1.66	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	25.33	0.46	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	16.91	0.72	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	16.08	1.96	0.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	17.47	1.16	0.93	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	15.03	3.52	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	21.98	2.25	2.82	0.00
CD14+ Monocytes, donor2	11305-117B9	12.81	0.74	2.23	0.56
CD14+ Monocytes, donor3	11381-118B4	19.10	2.20	3.51	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	41.61	2.83	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	42.08	2.65	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	41.09	2.63	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	50.59	1.59	0.58	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	23.54	2.72	1.21	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	46.43	2.13	0.95	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	25.28	1.84	3.18	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	21.53	0.28	2.21	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	21.57	1.24	0.00	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.10	1.17	0.59	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.38	0.89	0.53	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.16	0.65	0.87	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.71	0.00	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	18.48	1.58	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	34.66	1.34	1.34	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	33.12	2.20	1.80	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	34.14	1.46	1.04	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	32.72	2.75	1.83	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.62	0.45	2.49	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	18.77	0.44	2.62	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	31.74	1.88	0.81	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.71	2.09	0.87	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	31.56	0.42	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	20.21	1.10	3.86	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	22.54	0.00	3.17	2.11
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	20.18	1.75	0.88	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	16.39	0.87	0.35	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	12.27	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	18.54	1.72	0.86	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	19.66	0.41	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.21	0.00	1.85	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	16.01	0.00	1.86	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	38.36	1.96	1.09	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	34.42	1.62	0.23	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	37.04	2.38	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	50.61	1.87	0.47	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	34.06	2.27	1.40	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	38.13	2.68	1.11	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	45.68	2.30	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	42.82	2.63	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	37.27	2.74	0.21	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	44.71	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	39.32	5.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	34.17	4.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	31.45	2.13	1.60	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	23.59	1.61	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	28.78	4.91	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	33.73	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	32.96	5.27	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	13.15	0.00	2.47	0.00
CD19+ B Cells, donor2	11624-122B4	11.61	0.00	2.90	0.00
CD19+ B Cells, donor3	11705-123B4	11.11	2.52	3.03	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	55.36	2.83	0.00	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	51.53	2.80	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	14.06	2.01	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	12.92	1.12	2.25	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	24.80	4.13	1.50	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	24.35	1.35	0.68	0.90
CD4+ T Cells, donor1	11225-116C1	6.07	2.14	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	4.29	1.84	0.61	1.22
CD4+ T Cells, donor3	11382-118B5	10.67	1.83	3.05	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	33.44	3.83	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	27.63	4.04	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	29.03	2.59	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	14.70	2.37	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	9.13	3.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	34.25	2.46	0.43	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	33.89	3.05	0.34	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	29.98	2.42	0.00	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	17.93	1.79	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	18.17	2.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	16.28	4.40	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	32.89	1.26	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	39.89	1.87	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	36.75	3.34	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	9.52	2.18	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	12.86	2.14	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	41.35	2.41	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	37.47	1.95	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	40.98	2.10	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	17.19	3.54	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	17.76	0.87	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	17.87	2.61	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	40.58	4.95	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	44.31	10.16	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	5.58	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	41.26	3.32	0.28	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	45.64	7.85	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	43.12	6.16	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	49.42	4.66	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	47.09	12.46	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	12.77	1.96	2.95	0.65
CD8+ T Cells, donor2	11307-117C2	16.14	0.00	3.00	0.75
CD8+ T Cells, donor3	11383-118B6	13.63	1.26	2.27	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	16.52	0.46	0.69	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.02	1.68	1.20	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.85	0.55	1.37	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	21.62	0.30	1.80	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	14.40	0.48	1.92	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.60	0.23	2.05	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.17	0.22	1.30	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	14.48	0.00	0.79	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.49	0.47	0.47	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.51	0.91	1.21	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.88	0.87	2.61	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	20.78	0.27	1.07	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	22.76	0.44	9.19	3.06
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	18.22	0.46	4.10	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	19.39	0.00	9.70	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	14.41	0.36	1.44	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.13	0.86	2.01	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	14.14	0.24	1.41	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	20.28	0.95	1.90	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.69	0.31	0.62	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.35	0.64	1.28	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.98	1.15	1.91	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.89	0.39	1.18	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	17.67	1.61	4.82	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	24.48	1.40	6.99	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	0.00	11.02	2.00
Cardiac Myocyte, donor1	11525-119I4	14.62	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	33.10	3.46	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	55.98	2.00	0.84	0.63
Chondrocyte - de diff, donor1	11261-116G1	55.12	2.43	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	54.73	2.49	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	41.30	2.16	0.68	0.80
Chondrocyte - re diff, donor2	11339-117F7	59.98	2.69	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	46.91	2.43	1.62	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	54.51	1.61	2.30	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	49.17	2.78	1.92	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	54.60	4.42	2.39	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	57.86	4.03	4.13	2.75
Corneal Epithelial Cells, donor1	11526-119I5	39.52	2.20	0.88	0.44
Corneal Epithelial Cells, donor2	11606-120I4	19.34	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	26.33	1.28	1.02	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.22	0.99	0.50	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	33.43	2.52	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	30.89	1.84	0.54	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	15.37	2.05	1.37	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	15.02	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	20.81	6.29	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	52.87	2.84	3.17	3.34
Endothelial Cells - Aortic, donor1	11263-116G3	55.74	1.76	1.76	4.11
Endothelial Cells - Aortic, donor2	11340-117F8	42.14	1.70	3.39	3.11
Endothelial Cells - Aortic, donor3	11412-118E8	30.28	2.36	2.36	1.18
Endothelial Cells - Artery, donor1	11264-116G4	40.72	1.45	5.24	3.20
Endothelial Cells - Artery, donor2	11341-117F9	44.23	3.06	2.35	1.41
Endothelial Cells - Artery, donor3	11413-118E9	58.73	3.51	3.86	2.80
Endothelial Cells - Lymphatic, donor1	11236-116D3	31.92	0.66	2.66	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	36.21	1.22	4.56	4.26
Endothelial Cells - Lymphatic, donor3	11393-118C7	28.47	0.28	3.38	4.23
Endothelial Cells - Microvascular, donor1	11265-116G5	56.75	4.16	3.86	2.97
Endothelial Cells - Microvascular, donor2	11342-117G1	40.61	2.08	2.60	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	36.30	2.55	3.83	2.69
Endothelial Cells - Thoracic, donor1	11266-116G6	47.21	1.20	6.40	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	47.17	1.57	4.72	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	41.50	2.36	1.24	2.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	33.89	2.39	1.96	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	40.79	2.56	2.08	1.59
Endothelial Cells - Vein, donor1	11267-116G7	39.81	4.55	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	46.10	2.10	0.70	1.40
Endothelial Cells - Vein, donor3	11416-118F3	50.40	3.30	1.73	1.73
Eosinophils, donor1	12244-129H3	76.23	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	69.31	1.65	9.90	8.25
Eosinophils, donor3	12246-129H5	42.80	7.13	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	27.12	1.47	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	55.42	2.46	4.52	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.58	0.77	0.44	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	51.57	2.60	1.73	2.60
Fibroblast - Aortic Adventitial, donor1	11245-116E3	54.58	1.94	1.21	1.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	58.68	1.77	1.23	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	50.84	2.11	1.27	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	51.91	0.79	4.74	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	59.46	2.33	2.33	2.33
Fibroblast - Cardiac, donor1	11268-116G8	73.94	2.72	1.36	1.36
Fibroblast - Cardiac, donor2	11345-117G4	72.01	1.52	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	45.42	2.37	1.89	2.21
Fibroblast - Cardiac, donor4	11452-119A3	47.28	2.73	0.30	1.21
Fibroblast - Cardiac, donor5	11456-119A7	53.43	2.28	1.27	1.02
Fibroblast - Cardiac, donor6	11460-119B2	53.36	2.43	1.52	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	89.91	3.48	1.21	1.88
Fibroblast - Choroid Plexus, donor2	11572-120E6	51.34	1.73	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	54.20	4.39	2.93	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	76.57	3.92	1.61	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	42.23	1.36	0.17	0.51
Fibroblast - Dermal, donor1	11269-116G9	48.83	2.35	0.94	0.70
Fibroblast - Dermal, donor2	11346-117G5	58.02	1.42	0.94	1.42
Fibroblast - Dermal, donor3	11418-118F5	58.63	2.78	0.73	1.33
Fibroblast - Dermal, donor4	11450-119A1	61.84	2.94	0.34	0.57
Fibroblast - Dermal, donor5	11454-119A5	78.85	2.97	0.70	0.87
Fibroblast - Dermal, donor6	11458-119A9	88.52	2.76	1.46	0.65
Fibroblast - Gingival, donor1	11237-116D4	60.39	3.75	0.83	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	80.43	2.10	2.88	3.67
Fibroblast - Gingival, donor2	11318-117D4	74.72	2.90	0.26	1.19
Fibroblast - Gingival, donor3	11394-118C8	41.87	2.22	0.48	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	85.19	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	51.80	1.23	1.41	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	66.10	3.43	1.25	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	72.35	1.22	1.49	2.03
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	70.22	2.12	6.35	3.18
Fibroblast - Gingival, donor7 (control)	11924-125H7	62.74	2.19	1.17	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	54.27	1.64	1.23	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	67.24	2.30	3.73	1.65
Fibroblast - Gingival, donor9 (control)	11927-125I1	55.32	1.03	1.32	1.17
Fibroblast - Lung, donor1	11270-116H1	93.80	2.72	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	47.75	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	79.56	5.06	0.63	2.11
Fibroblast - Lymphatic, donor1	11506-119G3	140.78	4.17	5.00	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	76.92	5.59	2.80	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	80.88	2.52	3.64	1.96
Fibroblast - Mammary, donor1	11540-120B1	89.31	3.65	3.25	3.25
Fibroblast - Mammary, donor2	11620-122A9	79.88	19.97	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	71.58	4.07	0.39	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	62.64	2.43	0.61	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	73.13	2.75	0.92	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	78.23	2.67	3.05	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	106.11	5.13	1.35	2.16
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	67.73	2.20	1.28	1.74
Fibroblast - Pulmonary Artery, donor1	11250-116E8	55.82	2.32	1.66	1.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	141.01	4.27	9.55	7.31
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	87.53	7.35	2.00	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	71.96	0.79	0.00	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	80.77	2.38	1.79	2.38
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	58.44	2.13	0.36	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	59.91	1.77	0.79	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	77.02	1.50	1.50	3.31
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	81.61	3.24	1.73	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	108.82	3.80	1.52	1.77
Fibroblast - skin normal, donor1	11553-120C5	81.71	1.97	0.98	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	75.79	1.40	1.00	1.60
Fibroblast - skin normal, donor2	11561-120D4	82.48	4.12	1.11	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	99.44	3.63	1.21	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	55.67	1.91	1.08	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	87.70	2.56	1.20	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	83.42	1.97	3.94	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	104.82	3.20	1.28	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	82.99	3.88	1.52	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	63.83	2.51	2.20	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	33.11	1.39	1.39	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	36.95	1.30	1.30	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	36.03	1.02	1.79	2.04
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	25.26	0.77	2.30	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	2.55	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	29.67	4.28	2.00	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	38.88	3.86	2.76	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	35.39	3.20	1.37	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	36.85	4.76	1.78	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.44	2.11	1.32	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	42.07	5.87	1.63	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.00	3.54	2.21	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	34.77	1.41	2.12	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	36.20	1.85	2.96	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	25.79	2.95	2.42	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	54.14	2.11	5.70	3.84
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	48.73	1.94	4.29	2.91
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	28.87	2.03	4.88	2.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	38.33	2.05	4.11	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	37.37	1.62	1.99	2.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	34.54	2.19	3.06	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	36.64	1.77	3.25	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	36.72	1.11	3.18	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	34.63	2.23	2.01	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	32.87	2.02	2.82	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	44.62	1.53	2.54	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	31.74	1.33	3.01	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.73	1.14	3.12	1.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	34.84	1.02	3.07	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	46.36	2.43	2.77	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.77	1.50	2.25	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.44	1.63	1.63	2.25
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	35.48	3.09	3.30	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	41.97	1.61	2.08	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	34.19	2.33	2.17	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	33.06	1.10	1.76	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	44.52	2.71	1.72	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	31.93	2.43	1.62	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	38.49	2.89	1.60	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	42.45	2.08	1.14	1.23
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	38.75	1.74	0.95	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	24.33	2.43	2.74	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	50.18	2.30	1.99	1.88
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.76	1.32	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.93	2.24	1.96	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	44.07	2.04	1.30	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	36.10	1.87	1.07	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	34.12	0.46	0.61	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	42.75	2.07	1.55	1.55
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	39.03	2.17	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	43.32	1.66	1.84	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	34.87	1.32	1.32	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	28.76	0.99	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	47.36	2.37	1.98	2.11
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	44.79	2.02	2.22	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	44.22	2.03	2.29	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	34.44	2.79	3.78	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	33.43	2.16	1.69	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	36.42	2.25	3.48	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.42	1.25	0.94	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	24.86	0.85	0.85	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	24.91	3.23	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	7.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	34.81	1.55	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	25.67	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	37.76	1.95	1.95	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	27.18	3.71	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	34.68	2.80	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	34.32	2.29	1.63	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	34.39	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	37.85	3.82	0.95	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	39.74	5.43	1.36	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	41.76	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	37.80	1.72	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	40.55	4.44	0.89	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	0.00	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	47.22	3.31	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	34.29	3.22	0.92	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	33.44	1.92	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	34.55	1.96	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	49.49	4.68	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	43.15	1.93	1.54	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	43.82	1.37	4.11	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	7.45	7.45	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	40.58	1.42	1.89	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	39.23	1.81	1.81	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	35.61	1.02	2.54	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	38.69	1.60	0.80	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	55.26	2.47	1.48	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	42.01	2.33	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	49.59	0.88	1.76	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	31.36	1.70	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	39.99	2.39	4.18	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	47.07	1.46	2.43	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	89.02	5.71	1.14	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	66.11	2.49	2.91	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	132.69	5.62	1.12	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	39.96	1.27	0.63	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	35.51	1.67	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.35	2.09	0.70	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	34.77	1.86	0.84	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	24.80	1.37	0.46	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	33.01	1.31	0.87	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	32.88	1.29	1.07	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	26.69	1.51	0.43	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.00	2.12	1.12	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	24.53	1.37	1.37	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	28.51	0.96	0.00	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	87.30	4.48	7.28	3.36
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	72.28	2.60	3.46	3.46
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	5.29	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	104.76	3.88	1.41	3.17
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	93.72	3.63	5.81	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	42.14	1.40	0.87	1.05
Hepatocyte, donor1	11523-119I2	24.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	19.39	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	23.31	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	5.87	3.92	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	29.01	1.22	1.40	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	41.57	1.37	0.69	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	33.23	2.77	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	32.53	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	28.34	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	27.79	0.00	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	31.04	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.30	2.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	3.09	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	33.59	1.29	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	33.81	4.83	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	23.63	2.44	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	27.29	1.68	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.09	4.02	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	29.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	25.96	0.47	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	21.77	1.81	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	27.98	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	31.76	2.54	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	33.80	1.28	1.91	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	27.85	2.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.14	1.23	1.23	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	26.34	3.51	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	21.56	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	34.88	5.23	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	6.97	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	44.80	2.13	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	33.25	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	32.21	1.84	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	63.53	9.08	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	44.41	4.23	1.06	2.11
Keratinocyte - epidermal, donor1	11272-116H3	14.04	0.33	0.41	0.41
Keratinocyte - epidermal, donor2	11349-117G8	33.38	1.17	0.59	1.17
Keratinocyte - epidermal, donor3	11421-118F8	29.15	1.51	0.19	0.19
Keratinocyte - oral, donor1	11251-116E9	35.42	1.02	0.11	0.57
Keratocytes, donor1	11527-119I6	53.98	1.72	1.03	0.69
Keratocytes, donor2	11607-120I5	65.62	1.17	0.00	1.17
Keratocytes, donor3	11688-122I5	22.53	0.99	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	0.00	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	59.33	2.16	2.16	3.24
Lens Epithelial Cells, donor2	11609-120I7	37.60	1.15	0.58	0.81
Lens Epithelial Cells, donor3	11690-122I7	47.93	2.52	3.23	2.32
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	34.98	1.90	2.96	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	19.54	0.84	2.51	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	32.74	1.73	2.99	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	28.50	1.08	3.23	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.84	0.95	1.58	2.21
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.83	1.94	3.02	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.44	1.64	1.64	2.46
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	34.13	1.01	2.28	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.35	1.13	3.10	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	21.36	1.19	2.77	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	24.82	0.78	1.55	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.14	1.48	2.04	1.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.43	2.09	2.44	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	26.24	1.91	1.67	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	24.04	1.37	1.79	2.06
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.48	1.54	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	24.94	1.87	2.81	1.56
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.01	0.73	2.74	2.01
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	23.37	1.32	0.99	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.19	1.46	1.17	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	31.86	1.24	2.24	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	28.61	0.97	2.91	2.91
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	21.01	0.54	2.42	2.69
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.34	1.51	2.42	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.33	0.52	3.11	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.47	1.26	2.51	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	27.07	1.35	2.26	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	26.14	1.38	4.82	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	21.64	1.51	1.88	1.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.52	0.95	1.38	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	22.29	1.94	3.39	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	16.54	0.99	2.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	22.42	1.86	2.23	1.61
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	28.88	1.11	0.37	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.55	0.99	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	23.10	1.51	1.79	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	21.87	1.29	1.93	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.87	0.61	2.74	2.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	23.09	1.40	1.82	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	28.80	1.07	1.78	2.13
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	16.00	0.00	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	21.94	1.24	1.87	1.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	28.65	1.07	1.79	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	26.13	1.31	1.63	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	26.84	1.65	1.18	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	43.31	2.23	2.72	3.84
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.19	1.28	2.05	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	23.27	2.69	3.88	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.18	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.13	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	12.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	0.70	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.76	1.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.57	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	8.14	0.58	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.90	1.35	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.08	0.27	0.27	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	9.24	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.35	1.76	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.66	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.54	0.53	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.77	0.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	8.59	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	3.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.25	1.25	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	7.01	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.32	0.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	9.27	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.72	1.11	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.96	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	5.53	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	3.45	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.98	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.36	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	15.59	1.64	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.94	0.90	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.03	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.18	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	9.29	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.78	1.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.33	0.67	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	9.05	1.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	13.51	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.25	1.37	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.05	0.00	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.08	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.71	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	9.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.61	1.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	7.27	2.18	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	10.85	0.49	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	13.07	1.51	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.07	1.35	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	13.36	0.89	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	11.73	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	7.26	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	13.49	1.04	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.06	0.00	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	11.18	1.12	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	12.37	1.77	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	14.27	0.77	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.65	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	17.78	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12.45	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	13.30	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	12.91	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.91	2.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	11.73	0.95	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.66	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	13.22	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	5.66	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6.37	2.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	12.48	1.13	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	11.23	0.83	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.83	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.86	1.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	8.36	1.86	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	4.68	2.01	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.44	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	10.10	1.62	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.89	0.00	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	15.39	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.85	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	0.89	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	9.88	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.27	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	2.08	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	43.08	1.82	0.00	1.37
Macrophage - monocyte derived, donor2	11313-117C8	39.64	2.39	0.37	0.55
Macrophage - monocyte derived, donor3	11389-118C3	38.28	2.10	0.00	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	35.58	1.06	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	49.75	0.48	3.17	1.90
Mallassez-derived cells, donor3	11930-125I4	48.09	2.50	3.06	2.50
Mammary Epithelial Cell, donor1	11273-116H4	27.10	0.60	0.70	0.70
Mammary Epithelial Cell, donor2	11350-117G9	24.90	0.29	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	47.14	1.50	0.75	1.00
Mast cell - stimulated, donor1	11487-119E2	35.93	0.68	1.36	0.00
Mast cell, donor1	11563-120D6	39.36	1.95	0.54	0.43
Mast cell, donor2	11565-120D8	66.57	3.27	6.54	1.78
Mast cell, donor3	11566-120D9	57.18	4.50	2.48	1.13
Mast cell, donor4	11567-120E1	66.13	4.43	3.55	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	41.25	2.22	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	15.18	0.58	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	57.59	3.21	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	48.87	3.18	0.67	0.84
Melanocyte - dark, donor1	11502-119F8	46.66	2.89	0.40	1.49
Melanocyte - dark, donor2	11582-120F7	27.69	1.73	1.38	1.04
Melanocyte - dark, donor3	11663-122F7	50.06	1.74	0.14	0.22
Melanocyte - light, donor1	11274-116H5	42.78	1.41	1.18	0.47
Melanocyte - light, donor2	11351-117H1	50.50	3.41	0.00	0.68
Melanocyte - light, donor3	11423-118G1	45.10	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	44.67	1.77	0.21	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	41.42	0.81	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	35.09	0.27	0.27	0.27
Meningeal Cells, donor1	11493-119E8	122.57	5.21	3.85	2.85
Meningeal Cells, donor2	11573-120E7	107.40	6.60	2.20	1.76
Meningeal Cells, donor3	11654-122E7	56.32	2.36	1.96	1.55
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	60.17	3.71	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	36.53	0.40	2.42	1.51
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	56.51	1.31	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	81.11	5.23	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	53.10	1.44	3.59	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	91.70	4.24	5.93	2.75
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	86.96	3.52	5.53	3.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	54.94	3.08	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	72.33	5.11	0.73	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	72.02	2.05	0.61	1.64
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	53.88	2.08	0.69	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	54.64	2.23	1.12	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	44.47	1.05	1.84	2.11
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	36.80	0.30	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	57.00	3.20	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	76.56	3.54	1.42	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	64.42	2.19	1.88	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.74	2.18	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	33.41	1.33	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	36.53	1.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	31.51	1.73	0.72	1.81
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	33.76	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	41.13	3.69	1.23	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	36.51	0.88	0.59	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	36.57	1.55	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	24.27	1.04	0.83	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	40.29	1.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.15	1.40	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	31.30	2.64	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.13	1.19	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.89	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	34.19	0.38	0.00	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	22.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.98	2.12	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	21.18	0.92	2.76	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.55	1.79	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	33.53	1.68	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	29.86	1.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	21.63	0.24	0.48	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	23.77	1.11	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	20.95	0.46	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	22.93	0.21	1.68	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.89	1.63	1.43	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	24.03	1.93	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	21.78	1.11	1.56	1.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	18.40	1.31	0.44	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.24	0.00	2.03	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	3.31	3.31	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	13.32	0.54	1.09	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.88	0.88	2.94	2.06
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	21.81	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	27.39	0.00	1.44	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	26.82	0.40	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	15.08	1.37	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	22.53	2.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	2.04	2.04	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	26.71	0.88	1.75	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	25.38	2.21	5.52	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.69	3.84	2.56	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	26.53	1.98	1.74	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	30.62	0.00	2.09	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	4.42	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	30.77	3.08	1.03	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	39.82	3.50	4.38	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	37.29	3.20	2.84	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	39.28	1.40	1.96	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	42.39	1.66	4.16	3.74
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	40.79	3.50	1.75	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	28.96	3.32	1.21	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	52.17	0.42	2.92	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	0.00	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	39.84	0.57	2.85	3.41
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	34.41	2.07	2.90	1.24
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	35.24	0.52	1.81	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	39.89	1.72	3.86	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	31.12	1.91	1.91	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	27.76	2.14	1.87	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	47.29	1.80	2.39	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	26.98	2.83	2.12	1.98
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	34.08	1.27	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	46.88	2.21	2.65	1.77
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	34.89	1.90	3.79	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	36.08	1.42	0.57	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	51.62	0.49	2.46	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	44.97	3.91	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.76	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	48.15	2.31	1.73	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	35.03	1.24	0.41	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	34.54	3.28	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	43.04	1.31	0.33	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	35.39	2.17	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	31.66	6.52	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	32.30	3.76	0.38	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	34.36	2.13	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	33.36	2.04	0.57	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	31.68	2.95	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	38.47	1.47	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	29.93	1.60	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	50.23	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	32.32	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	32.89	1.69	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	11.34	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	63.34	4.31	2.80	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	71.60	3.66	2.09	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	25.36	2.00	1.33	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.69	2.50	0.83	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	30.99	2.47	1.71	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	52.66	1.60	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	2.72	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	33.08	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.25	0.84	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	34.17	2.09	0.00	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.91	2.43	1.08	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.06	1.89	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	35.24	0.99	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.24	0.54	0.81	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	27.66	1.59	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.60	1.14	0.82	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	32.62	1.64	0.73	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.75	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	0.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.72	0.98	1.31	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	32.85	1.79	0.49	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	28.57	2.12	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.28	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	20.23	2.30	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	39.20	1.93	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	27.25	1.72	2.41	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	27.81	0.00	7.59	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.29	2.90	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.02	1.69	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.12	1.90	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	51.94	0.86	1.29	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	9.03	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	33.32	2.67	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.99	2.71	0.90	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	21.82	0.79	0.00	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	38.07	1.86	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	30.65	2.65	1.14	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	31.61	2.28	0.33	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.87	1.74	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	31.66	1.36	2.26	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	33.51	1.76	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	26.59	3.32	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	41.17	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	24.12	1.91	0.38	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	53.84	2.12	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	34.26	1.33	0.66	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.72	2.03	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	38.41	4.88	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.55	1.57	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	27.54	2.12	0.61	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	45.89	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	18.14	2.27	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	5.06	5.06	5.06
Myoblast, donor1	11241-116D8	45.22	1.49	1.24	1.37
Myoblast, donor2	11322-117D8	51.02	2.11	0.77	0.19
Myoblast, donor3	11398-118D3	52.30	4.20	0.50	1.68
NK T cell leukemia cell line:KHYG-1	10777-110G3	35.90	2.92	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	16.30	1.85	3.08	0.31
Natural Killer Cells, donor2	11311-117C6	11.76	0.30	2.11	0.60
Natural Killer Cells, donor3	11387-118C1	15.09	2.21	6.81	2.21
Neural stem cells, donor1	11275-116H6	25.41	0.36	3.27	2.90
Neural stem cells, donor2	11352-117H2	28.88	0.00	0.00	3.85
Neurons, donor1	11494-119E9	17.07	0.00	0.00	1.14
Neurons, donor2	11574-120E8	20.26	2.20	0.44	0.44
Neurons, donor3	11655-122E8	18.91	0.82	0.82	0.82
Neutrophils, donor1	11233-116C9	30.62	0.00	6.50	0.93
Neutrophils, donor2	11314-117C9	34.79	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	47.03	3.05	3.05	3.67
Nucleus Pulposus Cell, donor1	11252-116F1	39.78	1.66	0.12	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	31.26	1.30	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	60.37	3.01	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	57.68	1.93	2.06	1.93
Olfactory epithelial cells, donor2	11934-125I8	43.57	2.03	1.30	1.45
Olfactory epithelial cells, donor3	11935-125I9	49.03	1.70	1.25	1.02
Olfactory epithelial cells, donor4	11936-126A1	57.76	1.36	1.66	1.66
Oligodendrocyte - precursors, donor1	11496-119F2	42.73	2.41	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	54.02	1.49	0.43	2.13
Osteoblast - differentiated, donor2	11353-117H3	36.58	3.43	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	34.76	0.00	1.86	0.00
Osteoblast, donor1	11277-116H8	119.61	5.86	2.54	4.69
Osteoblast, donor2	11354-117H4	57.59	1.40	0.70	3.51
Osteoblast, donor3	11426-118G4	108.06	4.09	1.60	1.78
Pancreatic stromal cells, donor1	11249-116E7	65.70	2.44	2.19	1.60
Pericytes, donor1	11491-119E6	80.11	4.90	1.34	1.22
Pericytes, donor2	11571-120E5	78.78	5.21	0.23	0.45
Pericytes, donor3	11652-122E5	85.25	2.24	1.42	1.42
Perineurial Cells, donor1	11499-119F5	56.17	2.37	1.58	1.24
Perineurial Cells, donor2	11579-120F4	37.72	2.39	0.00	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	27.73	1.27	2.87	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	19.10	0.98	1.96	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	21.22	1.42	1.81	0.78
Placental Epithelial Cells, donor1	11278-116H9	33.96	1.43	0.96	0.96
Placental Epithelial Cells, donor2	11355-117H5	43.25	1.11	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	44.57	2.75	0.79	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	51.27	1.90	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	35.08	0.75	0.38	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	95.02	1.57	2.48	3.52
Preadipocyte - breast, donor2	11328-117E5	67.09	3.15	0.90	1.13
Preadipocyte - omental, donor1	11468-119C1	35.16	1.49	0.32	0.43
Preadipocyte - omental, donor2	11329-117E6	51.50	0.87	0.44	1.31
Preadipocyte - omental, donor3	11403-118D8	70.34	2.86	1.86	0.72
Preadipocyte - perirenal, donor1	11469-119C2	73.82	1.97	0.98	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	109.64	3.38	2.76	3.69
Preadipocyte - subcutaneous, donor2	11356-117H6	74.37	2.83	2.48	2.83
Preadipocyte - subcutaneous, donor3	11428-118G6	73.73	3.07	1.53	1.87
Preadipocyte - visceral, donor1	11280-116I2	55.05	2.24	1.02	1.21
Preadipocyte - visceral, donor2	11357-117H7	42.34	1.84	0.46	1.84
Preadipocyte - visceral, donor3	11429-118G7	70.32	2.61	0.63	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	21.72	0.75	2.11	1.51
Prostate Epithelial Cells, donor2	11331-117E8	18.15	0.27	0.81	0.81
Prostate Epithelial Cells, donor3	11404-118D9	8.94	0.31	0.06	0.18
Prostate Stromal Cells, donor1	11254-116F3	49.55	2.51	0.11	0.80
Prostate Stromal Cells, donor2	11332-117E9	62.22	2.51	2.87	1.97
Prostate Stromal Cells, donor3	11405-118E1	63.50	2.82	1.46	1.77
Renal Cortical Epithelial Cells, donor1	11516-119H4	52.19	0.73	1.46	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	26.13	0.69	1.11	0.83
Renal Epithelial Cells, donor1	11517-119H5	63.40	4.06	2.03	0.51
Renal Epithelial Cells, donor2	11597-120H4	66.86	3.56	0.00	2.85
Renal Epithelial Cells, donor3	11678-122H4	25.51	1.27	1.69	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	71.49	6.13	2.72	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	66.71	3.77	5.79	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	47.07	3.11	3.33	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	39.93	2.00	0.67	5.32
Renal Mesangial Cells, donor1	11518-119H6	80.77	4.62	2.86	2.64
Renal Mesangial Cells, donor2	11598-120H5	82.76	5.64	2.51	0.63
Renal Mesangial Cells, donor3	11679-122H5	72.96	4.72	3.61	1.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	63.62	1.61	1.07	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	51.02	2.95	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	56.12	3.28	1.54	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	26.45	0.78	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	32.97	1.99	0.85	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	32.93	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	21.33	0.50	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	40.09	1.60	0.13	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	6.25	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	10.46	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	8.70	1.16	2.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	27.18	2.08	1.17	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	27.01	1.99	0.20	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	24.43	1.45	0.67	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	40.19	2.36	0.74	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.85	0.82	1.28	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	26.58	0.92	0.92	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	25.74	0.96	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.11	1.21	0.91	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	28.67	1.43	0.36	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	30.27	1.72	2.01	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	29.19	0.75	0.86	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	32.08	1.77	0.66	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	22.18	0.76	1.53	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	26.64	1.86	1.30	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	22.92	1.50	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	37.56	4.11	1.59	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.74	1.95	1.07	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	28.45	1.72	0.76	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	33.11	2.56	0.85	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	25.51	1.68	0.84	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	27.17	1.03	0.85	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	33.91	1.82	1.28	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.61	0.98	1.23	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	31.43	2.01	0.54	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	22.88	1.89	3.07	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	24.40	1.39	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.30	3.04	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	27.58	0.83	1.04	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	18.36	1.33	1.77	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.90	2.09	0.63	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.88	2.29	1.88	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	26.40	2.21	1.19	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	27.57	1.16	0.96	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	28.89	1.89	2.58	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.95	1.23	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	24.79	1.64	0.82	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	28.29	1.19	1.02	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	32.11	3.55	0.30	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	26.39	0.53	2.67	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.53	1.11	0.28	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	27.38	3.33	0.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	22.77	1.21	1.21	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	27.50	1.60	0.28	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	20.61	2.10	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	16.32	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	33.66	0.98	0.98	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	19.65	0.87	0.73	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	18.25	1.22	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	24.41	0.60	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	19.90	0.90	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	21.57	0.30	1.20	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	23.38	1.65	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.34	1.07	0.21	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	14.42	1.80	0.60	0.60
Schwann Cells, donor1	11498-119F4	138.61	7.33	1.50	0.75
Schwann Cells, donor2	11578-120F3	44.23	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	63.53	2.85	0.66	0.66
Sebocyte, donor1	11220-116B5	41.63	1.10	1.10	1.64
Sebocyte, donor2	11301-117B5	21.14	0.46	0.92	1.38
Sebocyte, donor3	11378-118B1	37.10	2.27	0.21	1.24
Sertoli Cells, donor1	11255-116F4	62.95	8.28	1.66	4.97
Sertoli Cells, donor2	11333-117F1	42.37	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	34.22	0.88	0.53	0.44
Skeletal Muscle Cells, donor2	11358-117H8	36.87	3.61	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	155.50	10.87	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	57.03	2.04	0.31	0.31
Skeletal Muscle Cells, donor5	11455-119A6	47.86	2.23	0.30	0.59
Skeletal Muscle Cells, donor6	11459-119B1	66.79	3.08	0.62	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	50.65	2.27	0.50	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	49.80	2.00	0.86	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	55.95	3.47	0.50	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	34.21	1.52	1.01	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	76.00	5.07	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	98.80	5.50	1.10	1.79
Skin - palm, donor1	10286-104F7	21.49	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	14.13	0.29	0.86	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	23.72	1.64	2.45	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.59	0.65	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	13.90	0.00	0.83	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	15.61	0.84	0.70	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	41.23	1.27	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	8.84	0.60	0.30	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	48.14	3.09	2.47	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	40.91	0.89	2.00	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	97.58	5.29	1.76	8.23
Smooth Muscle Cells - Aortic, donor1	11283-116I5	80.88	1.77	2.21	2.21
Smooth Muscle Cells - Aortic, donor2	11360-117I1	82.69	3.15	1.58	2.36
Smooth Muscle Cells - Aortic, donor3	11432-118H1	105.07	3.86	1.55	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	3.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	84.24	2.53	1.86	2.79
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	62.28	2.44	0.89	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	78.35	4.10	1.02	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	70.65	2.28	0.98	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	79.74	2.36	1.77	2.66
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	49.12	2.85	1.57	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	73.69	3.42	0.81	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	32.57	2.13	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	75.52	1.77	2.02	2.27
Smooth Muscle Cells - Carotid, donor2	11362-117I3	85.69	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	119.21	5.25	2.86	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	52.80	2.06	0.88	1.03
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.42	2.58	1.08	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	54.58	3.04	1.05	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	79.35	3.25	2.47	2.17
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	87.31	5.39	3.23	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	85.17	3.29	1.20	2.09
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	101.74	5.12	1.37	2.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	38.24	1.33	0.31	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	29.69	0.91	0.70	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	47.10	1.59	0.68	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	127.40	3.62	2.42	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	52.46	2.38	1.59	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	83.62	2.13	2.00	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	37.82	1.75	0.38	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	43.88	1.01	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	83.08	3.02	4.22	5.13
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	97.52	3.75	6.00	3.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	502.67	0.00	3.88	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	90.69	1.86	2.33	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	58.57	2.02	0.00	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	52.34	3.13	0.94	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	43.36	1.47	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	60.73	3.17	0.75	1.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	50.45	0.93	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	99.16	3.60	4.17	5.04
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	127.73	5.10	4.08	4.59
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	154.19	7.33	6.21	4.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	51.43	1.68	1.40	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	65.10	1.26	1.93	2.26
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	30.48	0.48	0.95	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	99.09	2.94	3.91	2.94
Smooth Muscle Cells - Uterine, donor1	11258-116F7	81.97	2.87	6.19	3.31
Smooth Muscle Cells - Uterine, donor3	11466-119B8	97.72	4.39	1.46	4.97
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	24.88	1.17	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	33.85	2.38	0.53	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	27.15	0.74	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	39.89	2.16	3.59	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	40.03	2.56	1.70	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	55.14	1.58	1.58	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	22.35	1.02	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	23.56	1.60	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	23.41	0.42	0.84	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	34.38	1.38	0.00	0.00
Synoviocyte, donor1	11291-117A4	81.64	3.03	6.73	5.22
Synoviocyte, donor2	11368-117I9	42.24	2.18	0.84	0.50
Synoviocyte, donor3	11440-118H9	43.34	1.56	0.89	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	99.70	3.93	1.79	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	53.52	1.98	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	74.56	5.09	1.16	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	23.30	1.15	0.29	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	32.47	1.16	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	42.95	1.72	1.15	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	38.26	1.85	1.11	0.49
Urethra, donor2	10319-105A4	100.71	7.19	5.40	3.60
Urothelial Cells, donor1	11520-119H8	34.27	1.33	2.39	1.86
Urothelial Cells, donor2	11600-120H7	32.85	1.20	1.20	0.00
Urothelial Cells, donor3	11681-122H7	40.57	0.92	0.69	1.15
Urothelial cells, donor0	11216-116B1	40.12	0.67	1.34	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	118.34	8.01	0.89	5.34
Whole blood (ribopure), donor090309, donation2	12180-129A2	117.23	5.72	4.29	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	65.71	1.37	2.74	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	48.21	3.79	1.03	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.83	1.16	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	92.67	4.16	3.12	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	92.70	7.34	2.75	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	71.21	2.74	3.65	1.83
Wilms' tumor cell line:G-401	10809-111A8	31.09	2.59	3.45	1.48
Wilms' tumor cell line:HFWT	10597-108E3	22.00	2.64	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	45.81	1.96	1.40	0.84
achilles tendon, donor2	10292-104G4	53.73	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	24.48	2.04	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	13.23	2.79	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	19.23	3.80	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.97	2.18	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	17.71	3.37	0.28	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	23.05	3.60	0.42	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.16	1.91	0.54	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	21.59	1.32	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	19.60	2.04	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	26.40	5.05	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	18.03	1.29	0.92	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	26.96	2.79	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.42	2.33	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.32	2.34	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	19.98	4.18	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.68	2.47	2.88	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.51	4.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.90	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	32.15	1.21	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	24.79	1.93	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	25.17	2.00	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	15.01	1.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	1.86	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	32.39	2.64	5.65	4.90
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	19.19	2.18	3.49	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	29.99	0.00	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	22.84	1.65	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	38.00	1.55	0.31	0.78
adipose, donor1	10184-103D4	32.84	2.93	6.45	1.76
adipose, donor2	10185-103D5	27.58	2.03	2.03	1.22
adipose, donor3	10186-103D6	41.12	2.72	2.18	0.27
adipose, donor4	10187-103D7	76.27	0.87	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	39.14	3.47	1.26	0.95
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	17.88	0.53	0.80	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	34.30	0.71	1.07	0.71
amniotic membrane cells, donor1	12235-129G3	38.49	2.78	0.46	0.70
amniotic membrane cells, donor2	12236-129G4	61.20	1.35	1.01	0.34
amniotic membrane cells, donor3	12237-129G5	35.06	3.24	0.59	0.29
amygdala - adult, donor10196	10167-103B5	14.23	2.37	2.37	1.19
amygdala, adult, donor10252	10151-102I7	29.00	2.23	0.00	0.61
amygdala, newborn, donor10223	10360-105E9	12.27	1.61	3.23	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	53.48	1.91	1.40	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	22.72	1.76	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	25.39	2.67	0.33	0.00
aorta, adult, pool1	10052-101G7	178.28	7.65	4.31	3.53
appendix, adult	10189-103D9	64.43	5.05	1.16	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.76	1.03	1.03	0.34
artery, adult	10190-103E1	62.50	2.72	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	38.10	2.17	2.61	1.88
b cell line:RPMI1788	10427-106D4	18.74	2.53	0.74	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	125.68	3.88	3.88	4.44
bile duct carcinoma cell line:HuCCT1	10432-106D9	24.71	1.29	0.69	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	5.36	0.50	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.93	2.80	0.00	0.56
bladder, adult, pool1	10011-101C2	128.52	3.69	4.78	4.35
blood, adult, pool1	10053-101G8	53.15	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	50.52	2.57	2.57	2.57
bone marrow, adult	10192-103E3	43.86	2.70	2.02	0.00
brain, adult, donor1	10084-102B3	37.93	3.08	1.03	1.03
brain, adult, pool1	10012-101C3	24.72	2.23	0.22	0.22
brain, fetal, pool1	10085-102B4	34.73	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	20.48	0.66	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	36.57	2.75	0.50	0.37
breast, adult, donor1	10080-102A8	64.40	5.05	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	17.28	1.14	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	11.75	1.86	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	36.84	1.15	0.46	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	6.78	0.73	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	15.05	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	25.05	1.20	1.97	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	7.92	1.58	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	29.28	0.80	0.53	0.80
caudate nucleus - adult, donor10196	10177-103C6	19.57	3.45	2.30	3.45
caudate nucleus, adult, donor10252	10164-103B2	29.78	3.51	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	13.75	6.11	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	6.23	1.46	1.83	0.37
cerebellum - adult, donor10196	10173-103C2	34.96	2.91	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	34.38	4.27	0.00	0.21
cerebellum, adult, pool1	10083-102B2	30.70	4.48	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	19.10	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	33.53	4.54	1.51	0.76
cerebrospinal fluid, donor2	10294-104G6	19.73	2.19	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	23.87	1.01	0.43	0.43
cervical cancer cell line:ME-180	10553-107I4	20.55	0.83	0.50	0.17
cervix, adult, pool1	10013-101C4	111.50	5.77	3.25	3.04
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	58.80	3.20	1.53	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	33.96	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.49	2.11	0.12	0.37
choriocarcinoma cell line:SCH	10785-110H2	17.74	3.08	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	7.12	1.66	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	46.16	1.71	0.57	1.14
chorionic membrane cells, donor2	12239-129G7	121.60	5.47	4.67	2.98
chorionic membrane cells, donor3	12240-129G8	56.05	3.30	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	13.13	5.05	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.22	1.15	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	34.63	2.75	0.21	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	17.72	1.03	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	17.90	0.73	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	14.66	1.02	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	13.84	0.88	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	18.77	0.52	1.04	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	35.20	1.83	0.46	0.23
clear cell carcinoma cell line:TEN	10636-108I6	19.43	1.56	0.52	0.17
colon carcinoma cell line:CACO-2	10513-107D9	36.61	2.20	2.20	1.10
colon carcinoma cell line:COLO-320	10420-106C6	35.73	1.14	1.52	0.76
colon, adult, donor1	10082-102B1	145.18	7.14	1.19	3.57
colon, adult, pool1	10014-101C5	85.78	2.00	1.18	3.06
colon, fetal, donor1	10070-101I7	111.24	4.94	6.18	6.18
common myeloid progenitor CMP, donor1	12130-128D6	22.92	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	28.47	0.00	3.82	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	19.92	0.30	2.57	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	27.78	0.71	2.82	1.55
corpus callosum, adult, pool1	10042-101F6	44.22	5.09	0.66	1.00
cruciate ligament, donor2	10295-104G7	50.25	3.24	0.81	2.43
diaphragm, fetal, donor1	10069-101I6	60.19	7.22	2.41	2.41
diencephalon, adult	10193-103E4	24.96	3.84	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	15.84	2.53	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.46	1.03	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	28.16	0.72	2.17	1.20
ductus deferens, adult	10196-103E7	100.17	4.98	4.98	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	77.77	2.88	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	53.70	2.21	3.68	2.21
dura mater, adult, donor1	10041-101F5	27.75	2.23	1.98	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	28.43	2.00	10.66	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	23.21	1.43	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	14.80	1.23	1.85	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	19.07	0.61	1.21	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.36	1.85	2.78	0.93
embryonic pancreas cell line:2C6	10603-108E9	32.84	1.31	2.63	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	9.39	0.00	0.67	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	74.31	3.26	5.62	3.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	14.31	0.96	0.64	0.16
epidermoid carcinoma cell line:A431	10426-106D3	20.01	1.22	1.33	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	33.11	1.54	1.54	1.21
epididymis, adult	10197-103E8	57.77	2.30	2.51	3.14
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	50.21	1.77	1.42	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	23.20	0.79	1.97	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	37.48	1.44	4.32	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	34.74	1.57	3.35	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	39.88	2.46	2.69	0.78
esophagus, adult, pool1	10015-101C6	76.24	2.34	1.38	1.49
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	22.79	1.00	2.50	1.13
eye - muscle inferior rectus, donor1	10272-104E2	33.80	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	39.98	0.00	4.21	0.00
eye - muscle medial, donor2	10299-104H2	35.72	5.95	0.00	4.46
eye - muscle superior, donor2	10297-104G9	37.83	2.29	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	30.61	5.83	1.46	0.00
eye, fetal, donor1	10054-101G9	51.36	5.08	0.76	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	27.31	2.44	0.77	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	64.10	3.56	2.61	0.95
frontal lobe, adult, pool1	10040-101F4	27.96	2.63	0.56	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	25.52	1.20	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	15.82	0.73	0.27	0.27
gall bladder, adult	10198-103E9	96.33	1.69	2.17	1.93
gamma delta positive T cells, donor1	11937-126A2	36.51	3.76	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	47.43	2.61	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	23.66	1.69	0.00	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	12.77	0.97	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	23.12	1.64	1.31	0.33
gastric cancer cell line:GSS	10560-108A2	19.22	3.66	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	26.04	2.51	2.28	0.46
giant cell carcinoma cell line:LU65	10487-107B1	9.06	0.57	0.57	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	31.49	1.82	1.82	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	14.47	0.50	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.84	1.79	3.38	1.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	44.10	1.97	2.81	1.97
glioblastoma cell line:T98G	10485-107A8	39.07	1.10	0.22	0.55
glioma cell line:GI-1	10413-106B8	20.79	1.17	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	28.43	3.64	2.92	0.73
globus pallidus, adult, donor10252	10161-103A8	44.91	2.93	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	31.49	4.11	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	14.39	0.53	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	34.26	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	40.00	0.96	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	19.74	2.75	4.13	1.38
hIPS +CCl2, biol_rep2	14384-156C1	16.46	2.29	2.29	0.46
hIPS +CCl2, biol_rep3	14385-156C2	18.03	3.22	0.64	1.29
hIPS, biol_rep1	14380-156B6	11.50	1.44	4.31	0.00
hIPS, biol_rep2	14381-156B7	16.46	1.37	4.12	0.69
hIPS, biol_rep3	14382-156B8	16.55	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	27.30	2.30	1.15	0.29
heart - mitral valve, adult	10205-103F7	72.05	2.69	3.59	3.89
heart - pulmonic valve, adult	10206-103F8	101.19	4.71	4.97	4.71
heart - tricuspid valve, adult	10207-103F9	38.30	2.50	3.33	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	61.63	4.49	0.82	1.22
heart, adult, diseased, donor1	10051-101G6	73.67	5.54	0.43	1.70
heart, adult, pool1	10016-101C7	69.68	4.14	0.46	0.92
heart, fetal, pool1	10046-101G1	103.40	5.96	7.39	4.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	70.96	2.78	3.09	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	24.42	1.22	4.64	1.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	29.86	0.73	3.76	1.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	22.84	1.82	4.85	2.43
hepatoma cell line:Li-7	10484-107A7	15.68	1.11	0.56	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	26.63	1.71	1.01	0.90
hippocampus - adult, donor10196	10169-103B7	22.71	0.95	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	37.35	2.86	0.20	0.61
hippocampus, adult, donor10258	10374-105G5	14.44	2.99	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	7.05	2.11	1.41	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	20.75	3.05	3.05	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	26.90	1.37	0.79	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	18.28	2.29	1.52	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	28.19	5.07	2.26	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.53	3.36	1.03	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	30.37	0.38	3.80	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.06	0.00	2.04	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	31.24	1.51	2.59	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.44	2.92	1.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	36.70	2.60	2.60	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	37.77	2.89	2.09	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	28.28	2.69	1.35	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	26.29	1.72	2.03	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	24.07	2.46	2.95	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	14.84	0.00	1.75	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	32.45	2.29	3.82	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	35.76	1.74	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	23.99	2.00	2.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	29.58	1.70	2.64	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	25.92	1.36	3.18	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	22.24	2.82	5.01	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	31.03	2.45	2.61	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	33.68	1.74	2.03	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	27.50	1.49	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	30.85	1.85	1.66	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	33.66	2.00	4.56	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	24.91	2.04	3.67	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	38.38	1.76	1.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	35.16	2.22	3.48	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	34.20	0.91	2.42	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	34.13	1.03	2.59	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	19.26	2.66	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.32	0.26	2.31	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	38.60	3.07	3.07	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	4.54	2.27	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	30.25	1.68	7.06	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	31.40	1.93	3.38	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.72	2.23	5.79	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	15.12	5.85	3.90	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	28.42	3.67	1.53	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	35.79	3.25	16.27	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	27.47	3.31	2.32	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	29.01	1.64	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	22.44	2.53	2.90	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	18.15	1.42	3.56	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	25.06	1.19	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	39.54	2.98	4.47	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	23.98	1.08	6.20	1.62
immature langerhans cells, donor1	11904-125F5	16.95	0.73	6.78	1.70
immature langerhans cells, donor2	11905-125F6	22.97	2.38	1.58	2.38
insula, adult, pool1	10039-101F3	27.54	2.37	0.57	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	17.56	1.30	0.00	0.00
kidney, adult, pool1	10017-101C8	49.96	2.20	1.40	1.60
kidney, fetal, pool1	10045-101F9	54.47	3.75	2.41	1.06
large cell lung carcinoma cell line:IA-LM	10509-107D5	23.15	1.42	3.12	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.99	0.69	0.55	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	12.66	0.92	0.92	0.37
left atrium, adult, donor1	10079-102A7	58.30	4.36	1.09	1.09
left ventricle, adult, donor1	10078-102A6	60.17	5.06	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	30.37	2.46	1.64	0.27
leiomyoma cell line:10964C	10569-108B2	42.75	3.59	2.51	2.16
leiomyoma cell line:15242A	10570-108B3	28.26	1.63	1.63	0.54
leiomyoma cell line:15425	10571-108B4	58.03	4.13	0.73	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	14.64	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	15.58	0.12	0.47	0.71
liposarcoma cell line:KMLS-1	10782-110G8	39.05	1.41	2.19	0.78
liposarcoma cell line:SW 872	10726-110A6	74.32	4.02	6.21	3.29
liver, adult, pool1	10018-101C9	26.74	0.81	0.49	0.32
liver, fetal, pool1	10086-102B5	52.68	3.76	3.76	2.82
locus coeruleus - adult, donor10196	10182-103D2	22.17	2.92	5.54	1.60
locus coeruleus, adult, donor10252	10165-103B3	33.96	2.40	0.00	0.37
locus coeruleus, adult, donor10258	10375-105G6	22.01	3.39	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	14.72	0.42	1.26	0.84
lung adenocarcinoma cell line:A549	10499-107C4	18.27	2.08	0.28	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	8.96	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	14.76	1.19	0.26	0.40
lung, adult, pool1	10019-101D1	47.49	2.13	2.36	1.89
lung, fetal, donor1	10068-101I5	90.76	3.14	9.42	4.28
lung, right lower lobe, adult, donor1	10075-102A3	54.53	1.37	3.67	1.83
lymph node, adult, donor1	10077-102A5	32.19	3.79	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	24.99	3.07	1.97	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	17.66	1.66	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	8.49	0.85	0.85	0.00
mature adipocyte, donor1	12231-129F8	58.61	4.88	0.00	0.44
mature adipocyte, donor2	12232-129F9	55.41	2.08	0.83	0.62
mature adipocyte, donor3	12233-129G1	53.34	3.79	0.71	0.71
mature adipocyte, donor4	12234-129G2	42.11	3.16	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	10.01	0.71	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	22.56	4.51	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	33.29	2.57	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	22.24	2.86	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	6.40	2.13	1.71	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	23.63	2.70	2.70	2.19
medial temporal gyrus, adult, donor10252	10156-103A3	32.68	2.97	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	13.28	2.51	1.44	0.36
medulla oblongata - adult, donor10196	10174-103C3	20.12	3.89	2.60	0.65
medulla oblongata, adult, donor10252	10155-103A2	32.35	4.18	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	32.98	2.61	0.98	0.98
medulla oblongata, newborn, donor10223	10361-105F1	17.36	1.39	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	9.30	1.11	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	30.45	2.08	1.22	0.00
melanoma cell line:COLO 679	10514-107E1	17.11	0.57	0.00	0.00
melanoma cell line:G-361	10465-106H6	24.43	0.81	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	30.21	1.27	0.36	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	18.50	1.76	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	11.92	2.07	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	81.01	3.22	1.23	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	65.62	1.64	0.73	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	41.82	0.83	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	50.43	2.39	0.28	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	61.43	2.31	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	34.01	1.39	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	36.04	1.72	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	55.67	2.07	0.23	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	75.07	3.71	1.99	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	79.67	3.78	2.70	2.43
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	94.04	4.98	2.70	3.27
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.69	0.66	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	91.33	2.63	3.60	2.91
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	67.37	3.49	0.70	4.89
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	70.85	1.63	0.20	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	67.22	1.80	4.67	5.03
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	58.97	1.45	0.62	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	29.87	0.91	1.82	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	66.71	0.84	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	118.50	3.29	2.09	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	64.07	3.24	0.70	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	50.44	0.74	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	70.39	2.86	6.01	2.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	62.73	3.79	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	83.57	2.74	0.91	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	69.06	2.30	0.77	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	63.08	2.62	0.79	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	60.69	2.16	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	55.54	1.88	1.41	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	53.48	3.72	1.69	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	64.84	1.18	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	46.80	1.85	1.85	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	71.82	1.15	0.29	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	53.10	3.35	1.12	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	61.05	2.88	1.20	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.87	3.67	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	46.32	3.36	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	50.76	0.82	2.46	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	52.84	1.29	0.86	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	51.95	2.73	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	67.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	62.03	3.90	2.27	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	50.92	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	70.90	1.60	1.07	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	50.70	4.91	0.82	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	52.87	1.55	0.39	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	6.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	36.76	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	52.77	2.37	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	59.70	3.66	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	49.40	3.17	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	35.18	1.03	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	55.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	21.19	1.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	27.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	21.81	2.95	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	22.44	0.62	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	34.75	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	34.30	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	35.11	2.07	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	29.19	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.81	1.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	25.39	0.81	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	25.49	3.03	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	3.29	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	28.97	0.79	0.20	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	36.99	2.27	0.00	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	35.65	5.09	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	56.48	5.42	6.96	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	35.20	2.36	3.31	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	20.39	0.46	1.62	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	4.27	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	30.93	1.23	3.19	1.44
mesothelioma cell line:Mero-25	10850-111F4	24.06	1.13	9.08	0.68
mesothelioma cell line:Mero-41	10851-111F5	30.31	1.47	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	33.21	1.99	0.89	0.44
mesothelioma cell line:Mero-82	10853-111F7	22.08	0.79	2.89	1.05
mesothelioma cell line:Mero-83	10854-111F8	29.96	1.19	1.02	0.51
mesothelioma cell line:Mero-84	10855-111F9	12.13	1.52	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	23.40	1.24	0.62	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	60.63	1.16	1.82	2.15
mesothelioma cell line:NCI-H226	10846-111E9	34.39	1.63	1.45	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	28.87	0.68	0.51	1.02
mesothelioma cell line:NCI-H28	10845-111E8	14.76	0.76	0.25	0.00
mesothelioma cell line:No36	10857-111G2	29.03	0.65	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	27.10	1.08	0.54	0.81
migratory langerhans cells, donor1	11901-125F2	49.71	2.69	2.11	1.34
migratory langerhans cells, donor2	11902-125F3	47.87	1.95	0.73	0.24
migratory langerhans cells, donor3	11903-125F4	37.69	2.87	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.98	0.65	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	49.80	4.03	0.64	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.26	0.69	1.38	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	48.14	1.90	2.85	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	31.05	2.77	0.18	0.74
myeloma cell line:PCM6	10474-106I6	28.46	1.38	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	41.60	3.55	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	38.25	1.96	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	13.59	0.56	0.11	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.55	0.07	0.29	0.15
nasal epithelial cells, donor2	12227-129F4	34.78	0.55	0.55	1.66
neuroblastoma cell line:CHP-134	10508-107D4	10.35	2.53	0.92	0.00
neuroblastoma cell line:NB-1	10539-107G8	13.10	0.94	0.56	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	14.55	2.11	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	21.43	3.35	0.19	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	9.96	2.61	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	26.29	2.22	0.32	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	18.52	1.81	0.00	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.72	3.81	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	60.95	2.93	1.33	1.86
neutrophil PMN, donor1	12133-128D9	89.25	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	19.11	1.52	0.51	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	20.81	1.60	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	67.97	3.53	1.28	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	88.29	2.89	4.73	5.78
nucleus accumbens, adult, pool1	10037-101F1	28.59	2.44	0.37	0.56
occipital cortex - adult, donor10196	10172-103C1	24.72	6.18	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	39.18	4.03	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	10.55	0.73	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	34.64	2.89	0.00	0.79
occipital lobe, fetal, donor1	10073-102A1	38.62	5.58	0.86	0.86
occipital pole, adult, pool1	10036-101E9	27.36	2.60	0.71	0.55
olfactory region, adult	10195-103E6	31.14	2.29	1.15	0.57
optic nerve, donor1	10277-104E7	34.02	6.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	15.49	0.80	0.57	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	19.23	0.69	0.41	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	23.87	1.35	1.52	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.39	0.58	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	54.68	2.94	1.47	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	35.50	4.67	8.41	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	31.60	1.27	3.18	1.27
ovary, adult, pool1	10020-101D2	52.67	3.41	0.96	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	44.55	3.12	3.30	1.65
pancreas, adult, donor1	10049-101G4	46.09	4.70	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.06	0.84	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	54.17	2.56	3.41	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	27.65	1.32	1.66	0.33
paracentral gyrus, adult, pool1	10035-101E8	29.20	2.11	0.37	0.92
parietal cortex, adult, donor10258	10373-105G4	30.09	4.40	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	28.21	3.76	1.88	0.94
parietal lobe, adult, donor10252	10157-103A4	25.94	2.57	0.57	0.57
parietal lobe, adult, pool1	10034-101E7	31.46	2.64	2.29	0.97
parietal lobe, fetal, donor1	10072-101I9	31.03	3.88	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	8.97	1.12	1.50	0.37
parotid gland, adult	10199-103F1	57.35	1.85	0.00	0.62
penis, adult	10200-103F2	70.90	5.91	2.69	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.69	2.23	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	22.15	1.60	0.87	0.44
pineal gland - adult, donor10196	10179-103C8	29.03	4.52	1.94	0.65
pineal gland, adult, donor10252	10160-103A7	46.19	5.33	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	35.74	2.51	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	39.46	4.05	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	33.88	2.08	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	26.39	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	45.37	1.72	1.61	2.15
plasma cell leukemia cell line:ARH-77	10840-111E3	18.27	0.66	0.93	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	32.68	1.87	0.31	0.47
pons, adult, pool1	10033-101E6	26.68	2.58	0.69	0.26
postcentral gyrus, adult, pool1	10032-101E5	29.73	3.40	0.26	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	10.46	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	29.42	2.04	0.73	0.87
prostate cancer cell line:PC-3	10439-106E7	34.67	1.82	0.73	0.00
prostate, adult, pool1	10022-101D4	91.69	2.99	2.18	1.27
putamen, adult, donor10196	10176-103C5	27.86	2.36	1.89	1.18
putamen, adult, donor10252	10152-102I8	37.25	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	17.48	4.37	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	14.01	3.14	0.48	0.24
putamen, newborn, donor10223	10365-105F5	6.75	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	12.22	0.29	0.58	0.00
rectum, fetal, donor1	10067-101I4	166.92	13.91	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.86	1.27	0.42	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	39.35	0.83	2.07	2.07
retina, adult, pool1	10030-101E3	54.17	3.48	2.19	0.99
retinoblastoma cell line:Y79	10475-106I7	11.17	1.30	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	15.98	1.11	0.37	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.59	2.25	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	61.39	3.03	0.76	0.76
salivary acinar cells, donor1	11771-123I7	17.48	0.81	1.13	0.00
salivary acinar cells, donor2	11772-123I8	24.65	0.55	0.14	0.28
salivary acinar cells, donor3	11773-123I9	21.19	1.99	1.32	0.00
salivary gland, adult, pool1	10093-102C3	57.20	2.29	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	38.87	0.67	2.53	1.26
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	44.43	0.59	1.76	1.65
seminal vesicle, adult	10201-103F3	84.12	2.65	12.17	4.76
serous adenocarcinoma cell line:JHOS-2	10639-108I9	31.34	0.97	1.21	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	35.73	1.76	0.25	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	3.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.58	1.61	0.54	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	15.58	1.11	0.22	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	15.35	0.77	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	31.21	1.42	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	40.30	2.28	0.72	1.20
skeletal muscle, fetal, donor1	10066-101I3	80.40	6.03	3.02	1.01
skin, adult, donor1	10074-102A2	74.64	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	73.22	3.16	2.52	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	37.69	2.67	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	24.90	2.21	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	16.38	2.89	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	10.38	0.66	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.11	1.45	0.48	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	51.43	0.44	0.65	0.22
small intestine, adult, pool1	10024-101D6	51.84	2.87	1.19	1.55
small intestine, fetal, donor1	10064-101I1	61.42	4.91	2.95	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	25.13	0.51	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	203.15	6.72	8.53	6.98
somatostatinoma cell line:QGP-1	10781-110G7	19.57	0.80	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	29.36	3.67	1.84	1.38
spinal cord, adult, donor10252	10159-103A6	22.87	3.55	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	13.84	1.38	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	71.96	6.10	3.05	0.61
spinal cord, newborn, donor10223	10359-105E8	21.12	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	63.92	3.88	1.49	1.94
spleen, adult, pool1	10025-101D7	40.09	3.41	0.88	0.88
spleen, fetal, pool1	10044-101F8	53.16	3.65	3.18	3.18
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	20.08	1.14	1.14	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	14.43	0.19	0.76	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	32.50	1.75	0.70	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	21.89	1.17	1.56	2.74
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	16.77	0.56	0.34	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	6.78	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	66.00	3.38	5.08	2.54
stomach, fetal, donor1	10062-101H8	100.39	7.48	21.36	1.07
submaxillary gland, adult	10202-103F4	35.89	1.14	0.57	1.71
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	34.06	1.25	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	10.35	5.17	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	14.13	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	17.42	0.92	0.00	0.46
temporal lobe, adult, pool1	10031-101E4	26.28	2.54	0.93	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	47.72	14.25	0.00	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	28.13	5.27	0.00	0.44
tenocyte, donor1	11763-123H8	65.63	2.09	0.70	1.75
tenocyte, donor2	11765-123I1	46.54	1.14	0.38	1.14
tenocyte, donor3	11768-123I4	55.60	1.48	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	28.55	2.38	0.51	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	48.09	3.85	1.23	1.08
teratocarcinoma cell line:PA-1	10807-111A6	43.24	3.25	0.77	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	31.48	1.40	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.99	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	28.90	0.44	0.11	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	14.98	3.26	0.33	0.00
testis, adult, pool1	10026-101D8	48.75	6.87	0.97	0.97
testis, adult, pool2	10096-102C6	25.71	4.96	1.35	0.45
thalamus - adult, donor10196	10168-103B6	30.91	3.31	3.31	2.21
thalamus, adult, donor10252	10154-103A1	32.35	3.28	0.00	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	17.79	1.65	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	4.60	1.15	2.30	0.00
throat, adult	10209-103G2	44.19	2.50	1.50	1.00
throat, fetal, donor1	10061-101H7	62.77	7.31	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	13.51	0.79	0.00	0.00
thymus, adult, pool1	10027-101D9	17.40	3.88	0.10	0.00
thymus, fetal, pool1	10043-101F7	30.13	4.68	1.04	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	40.29	0.80	3.32	2.13
thyroid carcinoma cell line:TCO-1	10783-110G9	61.46	4.05	1.54	1.54
thyroid, adult, pool1	10028-101E1	45.26	3.45	0.28	0.28
thyroid, fetal, donor1	10060-101H6	73.30	6.06	2.64	2.64
tongue epidermis (fungiform papillae), donor1	10288-104F9	43.11	0.00	0.00	0.00
tongue, adult	10203-103F5	25.58	2.09	0.47	2.09
tongue, fetal, donor1	10059-101H5	61.87	5.91	3.55	1.58
tonsil, adult, pool1	10047-101G2	31.15	2.30	0.50	0.30
trachea, adult, pool1	10029-101E2	35.99	1.80	0.49	0.74
trachea, fetal, donor1	10058-101H4	73.09	5.00	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	66.25	3.54	3.90	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	24.82	0.61	0.71	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	18.65	1.25	0.63	0.47
tridermal teratoma cell line:HGRT	10694-109G1	36.15	5.71	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.37	0.68	1.78	0.42
umbilical cord, fetal, donor1	10057-101H3	83.46	4.17	6.26	2.09
uterus, adult, pool1	10100-102D1	218.57	6.48	8.19	8.53
uterus, fetal, donor1	10055-101H1	165.35	10.24	3.07	2.56
vagina, adult	10204-103F6	47.17	1.94	0.00	1.29
vein, adult	10191-103E2	40.33	3.95	1.32	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	23.50	1.07	0.53	1.07

Property "Nearest transcripts" (as page type) with input value "LF207831:-17 MA443408:-17 ENST00000532063.5:-18 EU794625:147 LF369386:162 MA604963:162 KJ897056:436 KJ905216:436 KR709573:436 ENST00000627400.1:442 CU674762:442 AB463785:442 CR407673:442 DQ891172:442 DQ894355:442 ENST00000526318.2:466 LF369387:472 MA604964:472" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.